Neuropathy can be found developing eventually in approximately 50% of all diabetes patients. What about in prediabetes?… 

Even slightly elevated albumin was linked to raised odds of stroke, heart attack, heart failure….

A Danish registry study showed that patients with diabetes may not get as much benefit from clopidogrel (Plavix) for secondary prevention after a heart attack as nondiabetic patients…. 

Risk of lung cancer not lower in metformin-treated type 2 diabetes….

Changes in host-microbe interactions may lead to development of metabolic disorders and obesity….

The risk of diabetes may be different for people from different racial and ethnic backgrounds…. 

Prepared by Margarita Stanosyan, Doctor of Pharmacy Candidiate, LECOM College of Pharmacy, this terrific collection of Homerun Slides will give you everything you need to know about GLP-1 Analogs and how they help promote and work with the lifestyle changes your patients need to be addressing. Link to download (.ppt format): GLP-1 …

Cierra Harden PharmD Candidate 2013 LECOM School of Pharmacy, Bradenton Obesity is a major risk factor for the development of diabetes as well as predisposing individuals to hypertension and dyslipidemia. In the United States, 54.8% of persons with diabetes are obese, and 85.2% are overweight or obese1. All of these …

Alan Mathis PharmD Candidate 2013 University of Florida GLP-1 analogs not only improve plasma glucose levels and reduce HbA1c, but also improve metabolic effects such as reduction in BMI, waist circumference, and improve cardiovascular health. Diabetic patients, especially with type 2 diabetes, tend to have poor diets and sedentary lifestyle …

Andre McMahon, PharmD Candidate UF College of Pharmacy Achieving glycemic control is a critical goal in the management of patients with type 2 diabetes mellitus (DM). Hyperglycemia contributes to the progression of DM by adversely affecting both the body’s sensitivity to insulin and beta-cell function. Type 2 DM results from …